AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2024
Sep 6, 2024
33153_dirs_2024-09-06_a0495c41-15d8-4c42-926e-70982194117c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2024-09-01
Reporting Person: Sullivan John James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-01 | Common Stock | M | 1074 | — | Acquired | 27878 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-01 | Restricted Stock Units - 8 | $ | M | 1074 | Disposed | Common Stock (1074) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 44780 | Indirect |
Footnotes
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vested on September 1, 2024
F3: Not Applicable
F4: Represents a gift of shares to a spousal lifetime access trust
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6